233 related articles for article (PubMed ID: 18596154)
1. Immunotherapy reduces vascular amyloid-beta in PDAPP mice.
Schroeter S; Khan K; Barbour R; Doan M; Chen M; Guido T; Gill D; Basi G; Schenk D; Seubert P; Games D
J Neurosci; 2008 Jul; 28(27):6787-93. PubMed ID: 18596154
[TBL] [Abstract][Full Text] [Related]
2. Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta.
Racke MM; Boone LI; Hepburn DL; Parsadainian M; Bryan MT; Ness DK; Piroozi KS; Jordan WH; Brown DD; Hoffman WP; Holtzman DM; Bales KR; Gitter BD; May PC; Paul SM; DeMattos RB
J Neurosci; 2005 Jan; 25(3):629-36. PubMed ID: 15659599
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-beta vaccination, but not nitro-nonsteroidal anti-inflammatory drug treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid.
Wilcock DM; Jantzen PT; Li Q; Morgan D; Gordon MN
Neuroscience; 2007 Feb; 144(3):950-60. PubMed ID: 17137722
[TBL] [Abstract][Full Text] [Related]
4. Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalities.
Zago W; Schroeter S; Guido T; Khan K; Seubert P; Yednock T; Schenk D; Gregg KM; Games D; Bard F; Kinney GG
Alzheimers Dement; 2013 Oct; 9(5 Suppl):S105-15. PubMed ID: 23583235
[TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging.
Prada CM; Garcia-Alloza M; Betensky RA; Zhang-Nunes SX; Greenberg SM; Bacskai BJ; Frosch MP
J Neurosci; 2007 Feb; 27(8):1973-80. PubMed ID: 17314293
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging detection and time course of cerebral microhemorrhages during passive immunotherapy in living amyloid precursor protein transgenic mice.
Luo F; Rustay NR; Seifert T; Roesner B; Hradil V; Hillen H; Ebert U; Severin JM; Cox BF; Llano DA; Day M; Fox GB
J Pharmacol Exp Ther; 2010 Dec; 335(3):580-8. PubMed ID: 20823195
[TBL] [Abstract][Full Text] [Related]
7. Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice.
Thakker DR; Weatherspoon MR; Harrison J; Keene TE; Lane DS; Kaemmerer WF; Stewart GR; Shafer LL
Proc Natl Acad Sci U S A; 2009 Mar; 106(11):4501-6. PubMed ID: 19246392
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E markedly facilitates age-dependent cerebral amyloid angiopathy and spontaneous hemorrhage in amyloid precursor protein transgenic mice.
Fryer JD; Taylor JW; DeMattos RB; Bales KR; Paul SM; Parsadanian M; Holtzman DM
J Neurosci; 2003 Aug; 23(21):7889-96. PubMed ID: 12944519
[TBL] [Abstract][Full Text] [Related]
9. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
10. Passive immunotherapy targeting amyloid-β reduces cerebral amyloid angiopathy and improves vascular reactivity.
Bales KR; O'Neill SM; Pozdnyakov N; Pan F; Caouette D; Pi Y; Wood KM; Volfson D; Cirrito JR; Han BH; Johnson AW; Zipfel GJ; Samad TA
Brain; 2016 Feb; 139(Pt 2):563-77. PubMed ID: 26493635
[TBL] [Abstract][Full Text] [Related]
11. Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice.
Petrushina I; Ghochikyan A; Mkrtichyan M; Mamikonyan G; Movsesyan N; Ajdari R; Vasilevko V; Karapetyan A; Lees A; Agadjanyan MG; Cribbs DH
J Neuroinflammation; 2008 Sep; 5():42. PubMed ID: 18823564
[TBL] [Abstract][Full Text] [Related]
12. Reduced Efficacy of Anti-Aβ Immunotherapy in a Mouse Model of Amyloid Deposition and Vascular Cognitive Impairment Comorbidity.
Weekman EM; Sudduth TL; Caverly CN; Kopper TJ; Phillips OW; Powell DK; Wilcock DM
J Neurosci; 2016 Sep; 36(38):9896-907. PubMed ID: 27656027
[TBL] [Abstract][Full Text] [Related]
13. CD40L disruption enhances Abeta vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation.
Obregon D; Hou H; Bai Y; Nikolic WV; Mori T; Luo D; Zeng J; Ehrhart J; Fernandez F; Morgan D; Giunta B; Town T; Tan J
Neurobiol Dis; 2008 Feb; 29(2):336-53. PubMed ID: 18055209
[TBL] [Abstract][Full Text] [Related]
14. Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice.
Wilcock DM; Alamed J; Gottschall PE; Grimm J; Rosenthal A; Pons J; Ronan V; Symmonds K; Gordon MN; Morgan D
J Neurosci; 2006 May; 26(20):5340-6. PubMed ID: 16707786
[TBL] [Abstract][Full Text] [Related]
15. APOE Genotype Differentially Modulates Effects of Anti-Aβ, Passive Immunization in APP Transgenic Mice.
Pankiewicz JE; Baquero-Buitrago J; Sanchez S; Lopez-Contreras J; Kim J; Sullivan PM; Holtzman DM; Sadowski MJ
Mol Neurodegener; 2017 Jan; 12(1):12. PubMed ID: 28143566
[TBL] [Abstract][Full Text] [Related]
16. Anti-Aβ Antibodies and Cerebral Amyloid Angiopathy Complications.
Chantran Y; Capron J; Alamowitch S; Aucouturier P
Front Immunol; 2019; 10():1534. PubMed ID: 31333665
[TBL] [Abstract][Full Text] [Related]
17. Intracerebroventricular passive immunization in transgenic mouse models of Alzheimer's disease.
Chauhan NB; Siegel GJ
Expert Rev Vaccines; 2004 Dec; 3(6):717-25. PubMed ID: 15606357
[TBL] [Abstract][Full Text] [Related]
18. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of soluble, synaptotoxic amyloid β species by antibodies is epitope specific.
Zago W; Buttini M; Comery TA; Nishioka C; Gardai SJ; Seubert P; Games D; Bard F; Schenk D; Kinney GG
J Neurosci; 2012 Feb; 32(8):2696-702. PubMed ID: 22357853
[TBL] [Abstract][Full Text] [Related]
20. Blood-brain barrier integrity in a mouse model of Alzheimer's disease with or without acute 3D6 immunotherapy.
Gustafsson S; Gustavsson T; Roshanbin S; Hultqvist G; Hammarlund-Udenaes M; Sehlin D; Syvänen S
Neuropharmacology; 2018 Dec; 143():1-9. PubMed ID: 30201212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
